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Recently, Bock et al. (2008) proposed a semiautomatic method to quantify the angiogenesis and the 
lymphangiogenesis in corneal flat mounts. This model has proven suitability for unraveling the cellular and 
molecular mechanisms of inflammatory corneal lymphangiogenesis, as well as for evaluating the efficacy of 
novel drugs (Bock et al., 2007). The new method proposed by Bock et al. (2008) follows the classical steps of 
image analysis, i.e., image pre-processing in order to eliminate noise and enhance the contrast between the 
vessels and the background and then, a threshold transformation by which pixels belonging to vessels take the 
value of 1 (white pixels) and pixels for the background are scored 0 (black pixels). Once such a binary image is 
generated, Bock et al. (2008) measure automatically the area of the neovascularisation. This elegant 
methodology represents a great improvement as compared to the manual methods usually used to quantify the 
(lymph)angiogenic response observed in such murine model. 
The purpose of this letter is to show that additional morpho-metric parameters can be determinated from the 
binary processed image of the cornea leading to a more detailed characterisation of the corneal structure. Indeed, 
the vascularized area as determined by Bock et al. (2008) is a global measurement which enables an accurate 
determination of an increase/decrease of the vascularisation in the whole cornea, for example, as a function of 
time or when the cornea is submitted to pharmacological treatment. However, as it is a global measurement, it 
does not give insights into morphological changes of the vascular structure putatively induced by the treatment. 
Based on our expertise gained on image analysis of (lymph)angiogenesis in various experimental models 
(Blacher et al., 2001, 2005, 2008; Bruyere et al., 2008), we propose, in addition to the determination of area 
vascular density, to complete the description of the vascular tree of the cornea by measuring the five following 
parameters: (1) the total length density (δL) of vessel structure, which is a complementary measurement to the 
vessel area density (δA), (2) the density of vessel extremities (δV) which quantifies the increase/decrease of the 
number of new vessels, (3) the density of nodes (δn) (including branching and overlapping vessels) which 
characterizes the complexity of the structure, (4) the vessel density distribution which determines the spatial 
allocation of vessels, and (5) the maximal length of migration of vessels (Lmax). 
The pre-processing of images was performed as proposed by these authors with minor modifications due to the 
particular image acquisition conditions (microscope, camera...). Image analysis and statistics were performed 
using the Matlab software 7.1. A typical grey level image of the cornea and the corresponding thresholded image 
are shown in Fig. la and b, respectively. It is worth noting that physiological limbal vessels were erased manually 
in the binary image. From the thresholded image of vessels (Fig. lb), the total area of the vascular tree was 
determined automatically, as described by Bock et al. (2008). This value was divided by the total area of the 
cornea to obtain δA. The total length density (δL), the vessel extremities (δV) and nodes' (δn) densities were 
determined as described (Blacher et al., 2005). The skeleton of the vessel tree as well as the vessel extremities 
and nodes, obtained from the thresholded image (Fig. lb) are presented in Fig. 1c and d, respectively. It must be 
remarked that in Fig. lc, spurious vessels' extremities generated from removal limbic vessels, were eliminated. 
Image transformations used to measure the vessel density distribution and Lmax are described in Fig. le and f. 
In order to validate the proposed approach, it has been applied on whole mounts of cornea issued from mice 
treated or not with Ro-28-2653, an inhibitor of matrix metalloproteases (MMPs). Ro-28-2653 is a potent MMP 
inhibitor with high selectivity for MMP2, MMP9 and MT1-MMP (MMP14) (Maquoi et al., 2004) whose 
functions in pathological angiogenesis are well documented (Bergers et al., 2000; Hiraoka et al.,1998; Itoh et al., 
1998; Kato et al., 2001; Masson et al., 2005; Noel et al., 2008). Notably, MMP2 and MMP9 have been also 
implicated in choroidal angiogenesis (Lambert et al., 2003; Noel et al., 2007). In addition, the implication of 
these MMPs during lymphangiogenesis has emerged recently (Bruyere et al., 2008; Rutkowski et al., 2006). 
Mice of C57B16 background were intra-peritonealy injected, once a day during 9 days, with vehicle or RO-28-
2653 (30 mg/kg) prepared as previously described (Maquoi et al., 2004). Corneal lymphangiogenesis was 
induced by thermal cauterization of the central cornea with an ophthalmic cautery (OPTEMP II V, Alcon 
Surgical, Fort Worth, USA) two days after the first injection of MMP inhibitor. Typical grey level images of the 
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control and RO-28-2653-treated cornea as well as the spatial density vessel distribution are presented in Fig. lg-i, 
respectively. The measured densities δA, δL, δV, and δb, and Lmax are presented in Table 1. 
Global analysis of the vasculature as determined by the vessel area density (δA) and the total length density (δL) 
reveals that vessel growth was significantly inhibited by RO-28-2653. Furthermore, the decrease of the density 
of vessel extremities (δV) indicates that RO-28-2653 also blocked the sprouting of new vessels. Accordingly, the 
decrease of the density of nodes (δn) points out a less complex vascular structure. Such response is further 
confirmed by the wider spatial density vessel distribution for the control (see vessel density distribution in Fig. 
1i). It is worth noting that the maximal length of migration is not significantly different between the control and 
RO-28-2653-treated animals. This data with the decreased value of δb and δV reveal that RO-28-2653 inhibited 
the sprouting of new vessels but not the rate of large vessel migration. 
Altogether these data clearly demonstrate that the proposed methodology is suitable to pinpoint and quantify 
both global and local morphometric differences in the vascular network. Of major interest is the fact that this 
technique could detect any local morphologic changes of the lymphatic networks whereas the global density is 
unchanged, and vice versa. We therefore recommend completing the method reported by Bock et al. (2008) by 
evaluating the additional parameters described here to get information on the different steps of the 
lymphangiogenesis process (activation, proliferation and migration of endothelial cells). 
 
Table 1 
Statistical parameters for the vessel area density (δA), the area the total length density (δL), the density of vessel 
extremities (δV), the density of nodes (δn) as well as for the maximal length of migration of vessels (Lmax). ** 
indicates p < 0.01 in Wilcoxon test. N = 5. 
 δA** δL(l/mm2)** δV (l/mm2) δb (l/mm2) Lmax (mm) 
Control 0.1695 ± 0.0122 95.19 ± 3.89 42.31 ± 4.38 54.12 ± 3.97 0.98 ± 0.10 
RO-28-2653 0.1102 ± 0.0102 62.83 ± 5.37 26.02 ± 2.47 36.52 ± 4.09 0.95 ± 0.08 
 
 
Fig. 1. Lymphangiogenesis has been induced by corneal cauterization, (a) Typical image obtained in the corneal 
lymphangiogenesis assay, (b) corresponding thresholded image. Threshold was determined automatically using 
the entropy of histogram of grey level intensities (Kapur et al., 1985). (c) Vessel extremities and (d) node points 
are superposed (in green) to the skeleton of the vascular tree (in red). Parametric pruning transformation was 
applied to eliminate spurious branches (Soille, 1999). (e) Euclidean distance of the smallest polygon containing 
the cornea vascular tree. By this transformation, it is assigned to each pixel of the polygon a grey level intensity 
corresponding to the distance between that pixel and the nearest external border of the polygon. It is seen that 
pixels near the border of the polygon are dark (short distances) and lighten toward the centre of the cornea (high 
distances), (f) Allocation to each vasculature pixels of an intensity corresponding to the distance to the limit of 
the structure. Binary image of vessels (Fig. 1b) was multiplied (pixel by pixel) by the Euclidean distance of the 
polygon image (Fig. 1e). These results in a grey level image (Fig. 1f) in which each pixel which belongs to the 
vasculature takes an intensity corresponding to the distance to the limit of the cornea and the remainder pixels 
take intensity equal to 0. Statistical analysis of pixel intensities leads to the mean spatial distribution of each 
pixel belonging to the vessels as a function to the nearest border of the vascular tree. Typical grey level images 
of the control (g) and of the RO-28-2653-treated cornea (h) and the corresponding spatial density vessel 
distribution (i). ** indicates p < 0.01 in the Wilcoxon test. (For interpretation of the references to colour in this 
figure legend, the reader is referred to the web version of this article.) 
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